By Partha Ghosh, MD and Michal Cachovan, PhD
Data courtesy of Royal North Shore Hospital, Sydney, Australia
xSPECT Quant-based dosimetry over four 177Lu DOTATATE therapy cycles for treatment of neuroendocrine tumor metastases
2019-04-27
A patient with a neuroendocrine tumor and multiple functioning liver metastases was referred for 177Lu DOTATATE, underwent an abdominal SPECT/CT study on a Symbia Intevo™ 6 utilizing xSPECT Quant™ technology. The case highlights the reliable value of quantitative SPECT/CT and 3D voxel-based dosimetry tools.
Clinical case study